<DOC>
	<DOCNO>NCT02616328</DOCNO>
	<brief_summary>This single-arm , open-label , non-randomized , multicenter trial evaluate efficacy safety use tocilizumab confirm rheumatoid arthritis participant clinical practice .</brief_summary>
	<brief_title>A Study Efficacy Safety Tocilizumab Confirmed Rheumatoid Arthritis ( RA ) Participants Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Diagnosed moderatetosevere active rheumatoid arthritis ( RA ) 3 month Started tocilizumab , without previous history biological treatment Pregnant lactate woman Treated investigational drug within 30 day prior initiation study drug Having condition , opinion investigator , could compromise participant 's safety interfere study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>